Hypoceruloplasminemia-related movement disorder without kayser-fleischer rings is different from wilson disease and not involved in ATP7B mutation

European Journal of Neurology

Volumn 16, Issue 10, 2009, Pages 1130-1137

  Lirong, J ^a   Jianjun, J ^a   Hua, Z ^a   Guoqiang, F ^a   Yuhao, Z ^a   Xiaoli, P ^a   Xiaomin, Z ^a   Yuwen, Z ^a   Yu, M ^a   Jie, C ^a   Jihong, D ^a   Yueshi, M ^a   Zhenyao, M ^a   Chunjiu, Z ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

ATP7B gene; Kayser Fleischer rings; Movement disorder; Serum ceruloplasmin; Wilson disease

Indexed keywords

CERULOPLASMIN; COPPER; WILSON DISEASE PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CERVICAL DYSTONIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COPPER BLOOD LEVEL; CORNEA DISEASE; DISEASE COURSE; FEMALE; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOCERULOPLASMINEMIA RELATED MOVEMENT DISORDER; KAYSER FLEISCHER RING; MALE; MOTOR DYSFUNCTION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STAINING; URINALYSIS; WILSON DISEASE;

ADENOSINE TRIPHOSPHATASES; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CATION TRANSPORT PROTEINS; CERULOPLASMIN; COPPER; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; MIDDLE AGED; MOVEMENT DISORDERS; MUTATION; STAINING AND LABELING;

EID: 70349229546     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02733.x     Document Type: Article

References (23)

1. Scheinberg IH, Gitlin D. Deficiency of caeruloplasmin in patients with hepatolenticular degeneration. Science 1952 116 : 484 485.
2. Bull PC, Thomas GR, Rommens JM, et al. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993 5 : 327 337.
3. Logan JI, Harveyson KB, Wisdom GB, et al. Hereditary ceruloplasmin deficiency, dementia and diabetes mellitus. Q J Med 1994 87 : 663 670.
4. Schmidt CJ, Hamer DH, McBride OW. Chromosomal location of human metallothionein genes: implications for Menkes' disease. Science 1984 224 : 1104 1106.
5. Kumar N, Gross JB, Ahlskog JE. Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology 2004 63 : 33 39.
6. Xu X, Pin S, Gathinji M, et al. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Ann NY Acad Sci 2004 1012 : 299 305.
7. Harris ZL, Klomp LWJ, Gitlin JD. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am J Clin Nutr 1998 67 (suppl 972S 977S.
8. Barnes N, Tsivkovskii R, Tsivkovskaia N, et al. The copper-transporting ATPases, Menkes and Wilson disease proteins, have distinct roles in adult and developing cerebellum. J Biol Chem 2005 280 : 9640 9645.
9. Schlief ML, West T, Craig AM, et al. Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity. Proc Natl Acad Sci U S A 2006 103 : 14919 14924.
10. Menkes JH. Wilson disease. In : Schapira AHV ed. Neurology and Clinical Neuroscience. Philadelphia, PA : Mosby Inc., 2007 : 1447 1453.
11. Gow PJ, Smallwood RA, Angus PW, et al. Diagnosis of Wilson disease: an experience over three decades. Gut 2000 46 : 415 419.
12. Ala A, Walker AP, Ashkan K, et al. Wilson disease. Lancet 2007 369 : 397 408.
13. Das SK, Ray K. Wilson disease: an update. Nat Clin Pract Neurol 2006 2 : 482 493.
14. Walshe JM. Diagnostic significance of reduced serum ceruloplasmin concentration in neurological disease. Mov Disord 2005 20 : 1658 1661.
15. Bohrer D, Do Nascimento PC, Ramirez AG, et al. Comparison of ultrafiltration and solid phase extraction for the separation of free and protein-bound serum copper for the Wilson's disease diagnosis. Clin Chim Acta 2004 345 : 113 121.
16. Dedoussis GV, Genschel J, Sialvera TE, et al. Wilson disease: high prevalence in a mountainous area of Crete. Ann Hum Genet 2005 69 (Pt 3 268 274.
17. Sternlieb IH. Perspectives on Wilson disease. Hepatology 1990 12 : 1234 1239.
18. Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003 23 : 139 142.
19. King AD, Walshe JM, Kendall BE, et al. Cranial MR imaging in Wilson disease. Am J Roentgenol 1996 167 : 1579 1584.
20. Cullen LM, Part L, Cox DW. Genetic variation in the promoter and 5′ UTR of the copper transporter, ATP7B, in patients with Wilson disease. Clin Genet 2003 64 : 429 432.
21. Vassiliev V, Harris ZL, Zatta Paolo. Ceruloplasmin in neurodegenerative diseases. Brain Res Rev 2005 49 : 633 640.
22. Hussain F, Olson JS, Wittung-Stafshede P. Conserved residues modulate copper release in human copper chaperone Atox1. Proc Natl Acad Sci U S A 2008 105 : 11158 11163.
23. Vulpe CD, Packman S. Cellular copper transport. Ann Rev Nutr 1995 15 : 293 322.